Gene · 10189
Papers1,565
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,565
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma. | J Transl Med | 2025 | 40011918 | PubTator, text mining | PubMed |
| Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways. | Viruses | 2025 | 40006906 | PubTator, text mining | PubMed |
| Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers. | Front Oncol | 2025 | 39990690 | PubTator, text mining | PubMed |
| Plant viruses convergently target NPR1 with various strategies to suppress salicylic acid-mediated antiviral immunity. | J Integr Plant Biol | 2025 | 39981868 | PubTator, text mining | PubMed |
| mRNA Transcript Variants Expressed in Mammalian Cells. | Int J Mol Sci | 2025 | 39940824 | PubTator, text mining | PubMed |
| Upregulation of TTYH3 by lncRNA LUCAT1 through interacting with ALYREF facilitates the metastasis in non-small cell lung cancer. | Cancer Biol Ther | 2025 | 39930621 | PubTator, text mining | PubMed |
| RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancer. | Clin Transl Med | 2025 | 39915011 | PubTator, text mining | PubMed |
| RNA binding protein ALYREF regulates ferroptosis to facilitate LUAD growth and metastasis via promoting SLC7A11 mRNA stability. | Sci Rep | 2025 | 39779775 | PubTator, text mining | PubMed |
| 5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis. | Drug Resist Updat | 2025 | 39657434 | PubTator, text mining | PubMed |
| Global Co-regulatory Cross Talk Between m6A and m5C RNA Methylation Systems Coordinate Cellular Responses and Brain Disease Pathways. | Mol Neurobiol | 2025 | 39499421 | PubTator, text mining | PubMed |
| Sci-ModoM: a quantitative database of transcriptome-wide high-throughput RNA modification sites. | Nucleic Acids Res | 2025 | 39498498 | PubTator, text mining | PubMed |
| Adipose Tissue as a Major Launch Spot for Circulating Extracellular Vesicle-Carried MicroRNAs Coordinating Tissue and Systemic Metabolism. | Int J Mol Sci | 2024 | 39769251 | PubTator, text mining | PubMed |
| The molecular chaperone ALYREF promotes R-loop resolution and maintains genome stability. | J Biol Chem | 2024 | 39547511 | PubTator, text mining | PubMed |
| Insights into the Mode and Mechanism of Interactions Between RNA and RNA-Binding Proteins. | Int J Mol Sci | 2024 | 39518890 | PubTator, text mining | PubMed |
| Use of antibodies against Epstein-Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation. | Arch Virol | 2024 | 39514105 | PubTator, text mining | PubMed |
| ALYREF recruits ELAVL1 to promote colorectal tumorigenesis via facilitating RNA m5C recognition and nuclear export. | NPJ Precis Oncol | 2024 | 39455812 | PubTator, text mining | PubMed |
| RNA methyltransferase NSUN2-mediated m5C methylation promotes Cr(VI)-induced malignant transformation and lung cancer by accelerating metabolism reprogramming. | Environ Int | 2024 | 39395236 | PubTator, text mining | PubMed |
| ALYREF enhances breast cancer progression by regulating EZH2. | Heliyon | 2024 | 39386827 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| Cryo-EM structure of the CBC-ALYREF complex. | Elife | 2024 | 39282949 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10189/papers?page=6